Is CHRS forming a reversal pattern - 2025 Breakouts & Breakdowns & Precise Buy Zone Tips - Newser
12 hours ago • Google News
Coherus BioSciences Inc (CHRS)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 146.45M
P/E Ratio
2.38
Revenue (TTM)
$ 272.21M
Volume
0
52W High
$ 2.43
52W Low
$ 0.66
Dividend Yield
0.00%
Beta
0.90
Technicals
50-Day MA
0.9498
200-Day MA
1.0567
52 Week High
2.43
52 Week Low
0.6603
About CHRS
Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
Employees
177
Headquarters
Redwood City, CA
CEO
Mr. Dennis M. Lanfear